Articles by Rupesh J. Parikh, MD
A Patient-Centered Reconstruction of 340B in Oncology: Transparency, Equity, and Site-of-Care Accountability
ByLucio N. Gordan, MD,R. Steven Paulson, MD,David T. Wenk, MD,Paul A. S. Fishkin, MD,David R. Drosick, MD,Tracy W. Dobbs, MD,Richard M. Ingram, MD, FASCO,Rupesh J. Parikh, MD,Michael A. Danso, MD,Brian J. Heller, MD,Manojkumar Bupathi, MD, MS,David Cosgrove, MD,Mark T. Fleming, MD Community oncology leaders urge 340B overhaul so drug discounts follow vulnerable cancer patients, with audits, transparency, and tighter contract-pharmacy rules. This commentary will be featured on the Cover of the October issue of Evidence-Based Oncology.
